• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

53只猫恶性乳腺肿瘤的预后

Prognosis of malignant mammary tumor in 53 cats.

作者信息

Ito T, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N

机构信息

Department of Veterinary Surgery, Faculty of Agriculture, University of Tokyo, Japan.

出版信息

J Vet Med Sci. 1996 Aug;58(8):723-6. doi: 10.1292/jvms.58.723.

DOI:10.1292/jvms.58.723
PMID:8877968
Abstract

Medical records of fifty-three cats diagnosed as malignant mammary tumor from 1982 to 1993 were reviewed. The mean age of the cats at diagnosis was 11.1 years, and Japanese domestic and Siamese breeds were predominant. Survival rates after 1 and 2 years of diagnosis were 31.8% and 17.7%, respectively, suggesting poor prognosis of this malignancy. The survival time was significantly associated with tumor size or WHO clinical stage, but not with breed, age, or gender. Twenty-nine cats with pulmonary metastasis died within 5 months following metastatic detection. Postoperative prognosis was significantly related to the tumor size at surgery, but not with type of surgery and adjuvant chemotherapy using cyclophosphamide and/or vincristine.

摘要

回顾了1982年至1993年期间53只被诊断为恶性乳腺肿瘤的猫的病历。诊断时猫的平均年龄为11.1岁,日本本土品种和暹罗品种占主导。诊断后1年和2年的生存率分别为31.8%和17.7%,提示该恶性肿瘤预后不良。生存时间与肿瘤大小或世界卫生组织临床分期显著相关,但与品种、年龄或性别无关。29只发生肺转移的猫在检测到转移后5个月内死亡。术后预后与手术时的肿瘤大小显著相关,但与手术类型以及使用环磷酰胺和/或长春新碱的辅助化疗无关。

相似文献

1
Prognosis of malignant mammary tumor in 53 cats.53只猫恶性乳腺肿瘤的预后
J Vet Med Sci. 1996 Aug;58(8):723-6. doi: 10.1292/jvms.58.723.
2
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases.辅助多柔比星对比节拍式环磷酰胺和甲氨蝶呤对比手术单独用于治疗患有乳腺癌的猫:一项回顾性研究,涉及 137 例病例。
Vet Comp Oncol. 2021 Dec;19(4):714-723. doi: 10.1111/vco.12660. Epub 2020 Nov 9.
3
Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014).乳腺腺癌猫的手术入路与并发症发生率、无进展生存时间和疾病特异性生存时间的相关性:107例病例(1991 - 2014年)
J Am Vet Med Assoc. 2018 Jun 1;252(11):1393-1402. doi: 10.2460/javma.252.11.1393.
4
Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol.环磷酰胺、长春新碱和泼尼松龙(COP)联合化疗用于猫恶性淋巴瘤:旧方案的新结果
J Vet Intern Med. 2002 Mar-Apr;16(2):179-86. doi: 10.1892/0891-6640(2002)016<0179:cwcvap>2.3.co;2.
5
Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma.基于阿霉素的辅助化疗治疗猫乳腺癌的评估。
J Vet Intern Med. 2009 Jan-Feb;23(1):123-9. doi: 10.1111/j.1939-1676.2008.0244.x.
6
Lymphoma in cats treated with a weekly cyclophosphamide-, vincristine-, and prednisone-based protocol: 114 cases (1998-2008).采用基于环磷酰胺、长春新碱和泼尼松的每周治疗方案治疗的猫淋巴瘤:114例(1998 - 2008年)
J Am Vet Med Assoc. 2013 Apr 15;242(8):1104-9. doi: 10.2460/javma.242.8.1104.
7
Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases.多柔比星辅助治疗猫乳腺腺癌的回顾性评估:67例病例
J Am Anim Hosp Assoc. 2006 Mar-Apr;42(2):110-20. doi: 10.5326/0420110.
8
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.
Cancer Biother. 1995 Summer;10(2):125-30. doi: 10.1089/cbr.1995.10.125.
9
Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.米托蒽醌辅助化疗用于接受根治性乳房切除术治疗的猫乳腺癌。
J Feline Med Surg. 2015 Dec;17(12):1000-4. doi: 10.1177/1098612X14567159. Epub 2015 Feb 11.
10
Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981).猫淋巴瘤的治疗与预后因素:103例(1977 - 1981年)
J Am Vet Med Assoc. 1989 Mar 1;194(5):696-702.

引用本文的文献

1
Feline Mammary Tumors: A Comprehensive Review of Histological Classification Schemes, Grading Systems, and Prognostic Factors.猫乳腺肿瘤:组织学分类方案、分级系统和预后因素的综合综述
Vet Sci. 2025 Aug 5;12(8):736. doi: 10.3390/vetsci12080736.
2
Prognostic Insights in Feline Mammary Carcinomas: Clinicopathological Factors and the Proposal of a New Staging System.猫乳腺肿瘤的预后见解:临床病理因素及新分期系统的提议
Animals (Basel). 2025 Mar 10;15(6):779. doi: 10.3390/ani15060779.
3
Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma.
评估磷酸替罗尼布在患有大体型乳腺腺癌的猫中的疗效和安全性。
J Feline Med Surg. 2024 Aug;26(8):1098612X241256473. doi: 10.1177/1098612X241256473.
4
Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.犬猫乳腺肿瘤的流行病学和分类:泰国清迈二级保健医院 2012 年至 2019 年对 437 例乳腺肿瘤活检的组织病理学调查。
PeerJ. 2024 Mar 15;12:e17077. doi: 10.7717/peerj.17077. eCollection 2024.
5
The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells .姜黄素对猫乳腺肿瘤细胞的抗增殖和凋亡作用
Iran J Vet Res. 2021 Summer;22(3):222-229. doi: 10.22099/ijvr.2021.40452.5866.
6
Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma.猫乳腺癌中的新兴生物标志物与靶向治疗
Vet Sci. 2021 Aug 11;8(8):164. doi: 10.3390/vetsci8080164.
7
Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.干细胞多能性因子Sox2在猫浸润性乳腺癌中的不良预后影响
Front Vet Sci. 2021 Jan 22;7:622019. doi: 10.3389/fvets.2020.622019. eCollection 2020.
8
Metastatic feline mammary cancer: prognostic factors, outcome and comparison of different treatment modalities - a retrospective multicentre study.猫转移性乳腺肿瘤:预后因素、结果和不同治疗方式的比较——一项回顾性多中心研究。
J Feline Med Surg. 2021 Jun;23(6):549-556. doi: 10.1177/1098612X20964416. Epub 2020 Oct 20.
9
One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.犬猫浸润性乳腺癌的 1 年条件生存:源于人类乳腺癌的概念。
Vet Comp Oncol. 2021 Mar;19(1):140-151. doi: 10.1111/vco.12655. Epub 2020 Sep 28.
10
Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.肿瘤内胶原特征可预测猫乳腺肿瘤的临床结局。
PLoS One. 2020 Aug 10;15(8):e0236516. doi: 10.1371/journal.pone.0236516. eCollection 2020.